🔬 Clinical Research Protocol Framework — Ethical + Rigorous Study Design

Research Protocol: Early Mobilization + Postoperative Ileus — QI Project

A clinical research protocol produces rigorous design for ethical + useful research. NOT research advice — requires methodology + IRB expertise. This structure: QI protocol with publication potential.

Research Question + Hypothesis

Primary research question:

Does implementation of a structured early mobilization protocol reduce the rate of postoperative ileus in adult patients undergoing elective abdominal surgery?

Hypothesis:

• Null (H0): Early mobilization does not affect ileus rate.
• Alternative (H1): Early mobilization reduces ileus rate by 25% or more.

Expected direction: early mobilization → reduced ileus.

Literature support:

• Multiple studies suggest early ambulation reduces ileus
• Mechanism: GI motility stimulation, reduced inflammation
• Inconsistent implementation in practice

Study Design

Pre-Post Intervention Study (Quality Improvement):

Design rationale:

• QI project uses pre-intervention vs. post-intervention comparison
• Historical control (pre-protocol patients) vs. protocol cohort
• Institutional data access facilitates retrospective baseline
• Not RCT (QI, not formal trial)

Phases:

Phase 1: Baseline (3 months)

• Retrospective chart review of historical cohort
• Establish current ileus rate baseline
• Identify confounders to track

Phase 2: Protocol Implementation (1 month)

• Staff training
• Protocol rollout
• Run-in period (exclude first 2 weeks)

Phase 3: Data Collection (4 months)

• Prospective data on intervention cohort
• Primary outcome tracking
• Secondary outcomes

Phase 4: Analysis + Dissemination (1 month)

• Data analysis
• Internal reporting
• Publication preparation

Population + Sample Size

Inclusion Criteria

• Adult (18+) patients
• Elective abdominal surgery (specific types)
• At our institution
• During study period

Exclusion Criteria

• Emergency surgery
• Pre-existing ileus
• Patients unable to ambulate (cognitive, mobility issues)
• ICU admission post-op
• Specific procedures not amenable to early mobilization

Sample Size Calculation

Inputs:

• Baseline ileus rate (from literature): 15%
• Expected reduction: 25% relative (to 11%)
• Alpha: 0.05 (two-tailed)
• Power: 0.80

Calculation (two-proportion test):

• Required sample per group: ~900 patients
• Total: ~1,800 patients

Practical considerations:

• Our institution does ~600-800 elective abdominal surgeries annually
• 9-month data collection = ~400-500 intervention patients
• Historical baseline: 1-2 years = ~800-1,000 patients

Revised sample size: may be underpowered for primary outcome with 25% reduction. Consider:

• Smaller effect size (15% reduction) — requires even larger sample
• Longer study period
• Multi-site collaboration
• Accept underpower + report honestly

Decision: proceed with 9-month timeline + acknowledge power limitation. Primary finding may be non-significant — still valuable QI data.

Data Collection

Data Sources

• EHR (Epic) data extraction
• Operative notes
• Daily progress notes
• Nursing documentation
• Discharge summaries

Data Elements

Primary outcome:

• Postoperative ileus defined as: absence of bowel movement + tolerance of oral diet by POD 3 (or other standardized definition)

Secondary outcomes:

• Length of stay (hours)
• 30-day readmission
• Patient satisfaction (if available)
• Other complications (SSI, DVT, etc.)

Predictor variable:

• Mobilization protocol compliance (documented ambulation on POD 0 + POD 1)

Covariates (potential confounders):

• Age
• Gender
• BMI
• Comorbidities (diabetes, prior surgery, etc.)
• Procedure type + duration
• Surgical approach (open vs. laparoscopic)
• Anesthesia duration
• Analgesia regimen (epidural, opioids, multimodal)
• Nausea management
• IV fluid volume
• Bowel preparation

Data Collection Tools

Standardized data abstraction form:

• Patient demographics
• Surgery details
• Outcome measurements
• Protocol compliance
• Complications

REDCap database (secure, IRB-approved).

Pilot data collection: 20 patients to verify tool + identify issues before full rollout.

Data Quality

• Double data entry for 10%+ of records
• Missing data management plan
• Outlier identification + handling
• Regular quality checks

Ethical Considerations + IRB

IRB Submission

Project type: Quality Improvement

IRB determination likely:

• Exempt (if purely QI) or
• Expedited review (if research component)

Institution determines classification.

Required Elements for IRB

Protocol document:

• Background + significance
• Research question + hypothesis
• Study design + population
• Methods + outcomes
• Sample size calculation
• Data collection + analysis plan
• Ethical considerations
• Investigator roles

Consent considerations:

• If exempt/QI: waiver of consent
• If research: appropriate consent process
• Patient notification of QI activities

Privacy + confidentiality:

• HIPAA compliance
• De-identified data
• Secure storage (REDCap or approved system)
• Data access limited

Ethical Principles

Beneficence: protocol benefits patients (potentially).

Non-maleficence: minimal risk (early mobilization standard care).

Autonomy: patients can opt out of protocol if desired.

Justice: fair access across patient populations.

Potential Risks

• Theoretical: postoperative complications from early mobilization
• Mitigation: standard mobilization criteria, nursing oversight
• Safety monitoring: any adverse events reported

Vulnerable Populations

• Elderly patients: equal access with safety precautions
• Non-English speaking: interpreter services
• Pain or cognitive issues: individual assessment

Analysis Plan

Descriptive Statistics

• Patient demographics
• Surgery details
• Outcome rates
• Group comparisons

Primary Analysis

Compare ileus rates:

• Historical baseline vs. intervention cohort
• Chi-square test
• Adjusted analysis (multiple logistic regression)
• Control for known confounders

Secondary Analyses

• Length of stay: Wilcoxon rank-sum test + adjusted analysis
• Readmission: logistic regression
• Complications: chi-square + Fisher's exact for rare
• Subgroup analyses: pre-specified (open vs. laparoscopic, etc.)

Statistical Software

• R or SPSS (institutional access)
• Consultation with biostatistician recommended

Handling Missing Data

• Complete case analysis primary
• Sensitivity analysis with multiple imputation
• Transparency about missing data

Publication Plan

Target Journals

Primary targets:

• Journal of Hospital Medicine
• Annals of Surgery
• BMJ Quality & Safety
• American Journal of Surgery

Considerations:

• QI journal vs. clinical journal
• Impact factor
• Readership match
• Open access vs. traditional

Publication Requirements

CONSORT guidelines (if RCT): not primary given QI design.

STROBE guidelines: for observational design.

SQUIRE guidelines: for QI reporting.

Use SQUIRE as primary framework given QI nature.

Authorship

• Resident: first author
• Attending mentor: senior author
• Statistician if involved
• Key collaborators (nursing, surgery leadership)

Authorship criteria: ICMJE standards (substantial contributions, drafting, approval, accountability).

Dissemination Plan

• Institutional: department grand rounds
• Regional: local surgical society
• National: abstract submission to SAGES, ACS
• Journal publication
• Patient-facing: hospital newsletter

Timeline + Milestones

Month 1-3 (Baseline + Preparation)

• Protocol drafting
• IRB submission + approval
• Baseline data collection
• Staff training materials
• Pilot data collection

Month 4 (Protocol Implementation)

• Staff training sessions
• Protocol go-live
• Initial monitoring
• Address implementation issues

Month 5-8 (Data Collection)

• Prospective data collection
• Weekly audits
• Interim data review
• Adjustments as needed

Month 9 (Analysis + Dissemination)

• Statistical analysis
• Manuscript drafting
• Institutional presentation
• Conference abstract submission
• Journal submission

Key Takeaways

• Pre-post QI design with historical baseline + prospective intervention cohort. 9-month timeline. Sample size may be underpowered for 25% reduction but still valuable.
• IRB early engagement: QI determination (exempt vs. expedited). Consent waiver likely. HIPAA compliance + secure data handling throughout.
• Data collection via REDCap with standardized tools, pilot testing, quality control. Covariates captured for adjusted analysis.
• Analysis plan: primary (chi-square + logistic regression adjusted), secondary outcomes, subgroup analyses. Biostatistician consultation recommended.
• Publication plan from start: SQUIRE guidelines for QI, target journals identified, authorship criteria clear, dissemination across institutional + regional + national venues.